Vancomycin and the red-man syndrome: pharmacodynamics of histamine release. 1988

R E Polk, and D P Healy, and L B Schwartz, and D T Rock, and M L Garson, and K Roller
School of Pharmacy, Virginia Commonwealth University/Medical College of Virginia, Richmond.

Two regimens for infusing vancomycin over 1 h (500 mg every 6 h for five doses or 100 mg every 12 h for three doses) were used in 11 volunteers. Subjects received both regimens one week apart; the regimen used first for each subject was randomized. Nine receiving the 1000-mg dose experienced the "red-man (neck)" syndrome; none had the reaction while receiving the 500-mg dose (P = .002). Plasma histamine concentration, measured every 10 min during the first infusion of each regimen, increased in most subjects given 1000-mg doses; there was only a slight change in histamine levels after 500-mg doses. There was a significant relation between histamine release and reaction severity; frequency and severity of the reaction declined with subsequent doses. We conclude that the red-man syndrome occurs frequently in normal adults who receive 1000 mg of vancomycin over 1 h, that vancomycin causes an infusion rate-dependent increase in plasma histamine concentration, and that the increase in plasma histamine concentration is correlated with the severity of the reaction.

UI MeSH Term Description Entries
D008297 Male Males
D011537 Pruritus An intense itching sensation that produces the urge to rub or scratch the skin to obtain relief. Itching,Pruritis
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D003875 Drug Eruptions Adverse cutaneous reactions caused by ingestion, parenteral use, or local application of a drug. These may assume various morphologic patterns and produce various types of lesions. Dermatitis Medicamentosa,Dermatitis, Adverse Drug Reaction,Maculopapular Drug Eruption,Maculopapular Exanthem,Morbilliform Drug Reaction,Morbilliform Exanthem,Drug Eruption,Drug Eruption, Maculopapular,Drug Eruptions, Maculopapular,Drug Reaction, Morbilliform,Drug Reactions, Morbilliform,Eruption, Drug,Eruption, Maculopapular Drug,Eruptions, Drug,Eruptions, Maculopapular Drug,Exanthem, Maculopapular,Exanthem, Morbilliform,Exanthems, Maculopapular,Exanthems, Morbilliform,Maculopapular Drug Eruptions,Maculopapular Exanthems,Morbilliform Drug Reactions,Morbilliform Exanthems,Reaction, Morbilliform Drug,Reactions, Morbilliform Drug
D004890 Erythema Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes. Erythemas
D005260 Female Females
D006632 Histamine An amine derived by enzymatic decarboxylation of HISTIDINE. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter. Ceplene,Histamine Dihydrochloride,Histamine Hydrochloride,Peremin
D006636 Histamine Release The secretion of histamine from mast cell and basophil granules by exocytosis. This can be initiated by a number of factors, all of which involve binding of IgE, cross-linked by antigen, to the mast cell or basophil's Fc receptors. Once released, histamine binds to a number of different target cell receptors and exerts a wide variety of effects. Histamine Liberation,Histamine Liberations,Histamine Releases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

R E Polk, and D P Healy, and L B Schwartz, and D T Rock, and M L Garson, and K Roller
April 1991, Journal of cardiothoracic and vascular anesthesia,
R E Polk, and D P Healy, and L B Schwartz, and D T Rock, and M L Garson, and K Roller
April 1990, Lancet (London, England),
R E Polk, and D P Healy, and L B Schwartz, and D T Rock, and M L Garson, and K Roller
October 1990, Pediatrics,
R E Polk, and D P Healy, and L B Schwartz, and D T Rock, and M L Garson, and K Roller
January 1992, Harefuah,
R E Polk, and D P Healy, and L B Schwartz, and D T Rock, and M L Garson, and K Roller
August 1985, Lancet (London, England),
R E Polk, and D P Healy, and L B Schwartz, and D T Rock, and M L Garson, and K Roller
September 1991, Annals of internal medicine,
R E Polk, and D P Healy, and L B Schwartz, and D T Rock, and M L Garson, and K Roller
December 1986, Drug intelligence & clinical pharmacy,
R E Polk, and D P Healy, and L B Schwartz, and D T Rock, and M L Garson, and K Roller
June 1990, Lancet (London, England),
R E Polk, and D P Healy, and L B Schwartz, and D T Rock, and M L Garson, and K Roller
April 2018, Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia,
R E Polk, and D P Healy, and L B Schwartz, and D T Rock, and M L Garson, and K Roller
July 1987, Anesthesiology,
Copied contents to your clipboard!